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313 Can patient-reported health-related quality of life predict survival
in cystic ﬁbrosis?
J. Abbott1, A. Morton2, A. Hart1, S.P. Conway2, A.K. Webb3. 1Faculty of Health,
University of Central Lancashire, Preston, United Kingdom; 2Adult CF Unit,
Seacroft Hospital, Leeds, United Kingdom; 3Adult CF Unit, Wythenshawe Hospital,
Manchester, United Kingdom
Objective: This work aims to investigate the role of patient-reported, health-related
quality of life (HRQOL) in predicting survival in cystic ﬁbrosis.
Methods: All patients attended the Adult CF Units in Leeds and Manchester
in the UK. HRQoL, demographic and clinical variables were assessed during an
outpatient visit during 1996–1997. Clinical and demographic variables were: age,
gender, FEV1% predicted, BMI, access device, B. cepacia, diabetes, nutritional and
transplant status. HRQoL was measured using the Cystic Fibrosis Quality of Life
Questionnaire (CFQoL) which comprises 9 domains: physical functioning, social
functioning, emotional functioning, treatments, chest symptoms, future concerns,
relationships, body image and career issues. Survival analysis was undertaken using
Cox Proportional Hazards Regression in Intercooled STATA 9.
Results: At initial assessment there were 223 patients (age range 14 to 52 years;
121 females). On 31st December 2006, 154 were still alive and the death dates of 66
were known (3 were lost to follow-up). Even in the presence of FEV1% predicted
and all the other demographic and clinical variables, the physical functioning
domain of the CFQoL was an important predictor of survival. We are currently
investigating possible explanations for this.
Conclusion: Patient-reported physical functioning could be an important predictor
of survival, and may provide a signiﬁcant contribution to clinical monitoring.
314 Turkish translation and validation of revised Cystic Fibrosis
Questionnaire (CFQ-R) for children
H. Yuksel1, O. Yilmaz1, E. Eser2, A. Quittner3. 1Pediatric Allergy and
Pulmonology, Celal Bayar University, Manisa, Turkey; 2Public Health, Celal
Bayar University, Manisa, Turkey; 3Psychology, University of Miami, Coral
Gables, FL, USA
Developmental course of chronic diseases in children is inﬂuenced by physical,
psychological and social issues. Measurement of QoL is quantifying the results of
the disease and its treatment on the patient’s perception of a satisfying life. Cystic
ﬁbrosis (CF) is a chronic disease that involves multiple organ systems. Therefore
both the disease itself and its treatment may impair quality of life (QoL) in children.
On the other hand, there is no QoL questionnaire for children with CF in Turkish.
The aim of this study was to translate the Revised Cystic Fibrosis Questionnaire
(CFQ-R) into Turkish.
Translated CFQ-Rs included the ones for children aged between 6 and 11, 12 and 13,
14 and above and for parents of children aged between 7 and 13. The process started
with translation of CFQ-Rs into Turkish by two independent native Turkish speakers.
Then each question and answer in the two translations was compared on a telephone
conference with the author who has developed the form. Turkish translation is
ﬁnalized taking the best of the two translations. Finally back-translation of the
consensus Turkish CFQ-R is performed and reviewed on a telephone conference
again. Finally to make sure it is applicable to Turkish children and parents, ten CF
patients from each age group and ten parents were interviewed with one of the
researchers. Last changes were made after this interview.
At the end of the questionnaire, all four CFQ-Rs have been translated and ready
for use in Turkish children with CF. Validation and reliability study is still going
on.
Translation of CFQ-Rs into Turkish is expected to aid medical doctors and other
personnel in the care of children with CF.
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Little attention has been paid to PROs such as HRQoL in the management of adult
CF.
Aims: to compare measurement properties of a CF-speciﬁc measure, CFQoL, and
a generic HRQoL instrument, UKSIP, in an attempt to establish their relative value
as part of AR.
Methods: Patients with CF were recruited into the study from inpatient and
outpatient clinics of a specialist Adult Centre for CF and by post for those who
were not scheduled to attend the clinic during the study period. Patients were asked
to complete CFQoL and UKSIP at baseline (Test 1) and again at 7−10 day intervals
(Test 2).
Results: 118 were entered into the study of whom 70 took part (mean age 26,
median 23, range 17−61 years; 45 male). 39 (56%) were unemployed, 82% of
whom attributing it to their CF. The areas of HRQoL most impaired by CF
were employment (UKSIP) and had concerns regarding their future (CFQoL).
Psychosocial activities, particularly emotional behaviour, were more impaired
than physical (p< 0.05). UKSIP and CFQoL showed high reliability in the CF
population; Cronbach’s alpha internal consistency coefﬁcient (0.81−0.93) and test-
retest correlations (rs = 0.57−0.94, p< 0.005). HRQoL scores reﬂected patient-rated
overall health (very good to very poor-p< 0.05), showing discriminant validity.
Females reported poorer HRQoL in all UKSIP categories (p< 0.01). UKSIP scores
correlated with age (p< 0.01). CFQoL showed differences between severe and mild
disease and BMI (p< 0.01).
Conclusion: The ﬁndings of the study indicate that CF has a large impact on
HRQoL, and its assessment as part of CF annual reviews is recommended to provide
holistic patient care and may positively inﬂuence management of CF.
318 The role of parental supervision on medical adherence in
adolescents with Cystic Fibrosis
A.C. Modi1, K.K. Marciel2, S.K. Slater1, D. Drotar3, A.L. Quittner2. 1Behavioral
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Background: Previous research suggests that both parental supervision and adher-
ence decrease in adolescence, as the drive for independence and autonomy emerge
naturally during this period. However, no studies have examined this important
relationship in adolescents with cystic ﬁbrosis (CF).
Participants and Methods: The current study included 103 adolescents with CF
(M age = 13.4, 47% female, M FEV1% predicted = 82.1%, 94% Caucasian).
Activity patterns (medical and non-medical) were measured using the Daily Phone
Diary and adherence to nebulized medications was measured electronically.
Results: Controlling for sex and FEV1, signiﬁcant differences were found for time
spent in medical care activities [Hotelling’s T = 0.11, F(2,98) = 5.3, p< 0.01], with
younger adolescents spending more time with parents in medical activities than
older adolescents (M= 32.0 vs. M= 17.6 minutes). Results also indicated that time
spent with maternal but not paternal caregivers (b = 0.38 vs. b =−0.06) was the most
signiﬁcant predictor of better adherence to nebulized medications.
Conclusions: Results from this study indicated that parental supervision of CF
medical treatments declines with age, with maternal supervision being a signiﬁcant
predictor of adherence to nebulized medications. Overall these data suggest that
parents and adolescents are likely to beneﬁt from anticipatory guidance about how
to transition responsibility, as well as how to facilitate independence while also
rewarding good disease management.
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